460 related articles for article (PubMed ID: 30953770)
1. Toll-like receptor 9 antagonism modulates astrocyte function and preserves proximal axons following spinal cord injury.
Li L; Ni L; Eugenin EA; Heary RF; Elkabes S
Brain Behav Immun; 2019 Aug; 80():328-343. PubMed ID: 30953770
[TBL] [Abstract][Full Text] [Related]
2. Astroglial TLR9 antagonism promotes chemotaxis and alternative activation of macrophages via modulation of astrocyte-derived signals: implications for spinal cord injury.
Li L; Ni L; Heary RF; Elkabes S
J Neuroinflammation; 2020 Feb; 17(1):73. PubMed ID: 32098620
[TBL] [Abstract][Full Text] [Related]
3. Toll like receptor 9 antagonism modulates spinal cord neuronal function and survival: Direct versus astrocyte-mediated mechanisms.
Acioglu C; Mirabelli E; Baykal AT; Ni L; Ratnayake A; Heary RF; Elkabes S
Brain Behav Immun; 2016 Aug; 56():310-24. PubMed ID: 27044334
[TBL] [Abstract][Full Text] [Related]
4. A toll-like receptor 9 antagonist restores below-level glial glutamate transporter expression in the dorsal horn following spinal cord injury.
Pallottie A; Ratnayake A; Ni L; Acioglu C; Li L; Mirabelli E; Heary RF; Elkabes S
Sci Rep; 2018 Jun; 8(1):8723. PubMed ID: 29880832
[TBL] [Abstract][Full Text] [Related]
5. A toll-like receptor 9 antagonist reduces pain hypersensitivity and the inflammatory response in spinal cord injury.
David BT; Ratnayake A; Amarante MA; Reddy NP; Dong W; Sampath S; Heary RF; Elkabes S
Neurobiol Dis; 2013 Jun; 54():194-205. PubMed ID: 23313320
[TBL] [Abstract][Full Text] [Related]
6. Proliferating NG2-Cell-Dependent Angiogenesis and Scar Formation Alter Axon Growth and Functional Recovery After Spinal Cord Injury in Mice.
Hesp ZC; Yoseph RY; Suzuki R; Jukkola P; Wilson C; Nishiyama A; McTigue DM
J Neurosci; 2018 Feb; 38(6):1366-1382. PubMed ID: 29279310
[TBL] [Abstract][Full Text] [Related]
7. EphA4 Obstructs Spinal Cord Neuron Regeneration by Promoting Excessive Activation of Astrocytes.
Chen X; Zhang L; Hua F; Zhuang Y; Liu H; Wang S
Cell Mol Neurobiol; 2022 Jul; 42(5):1557-1568. PubMed ID: 33595805
[TBL] [Abstract][Full Text] [Related]
8. Increasing toll-like receptor 2 on astrocytes induced by Schwann cell-derived exosomes promotes recovery by inhibiting CSPGs deposition after spinal cord injury.
Pan D; Li Y; Yang F; Lv Z; Zhu S; Shao Y; Huang Y; Ning G; Feng S
J Neuroinflammation; 2021 Aug; 18(1):172. PubMed ID: 34372877
[TBL] [Abstract][Full Text] [Related]
9. GDNF modifies reactive astrogliosis allowing robust axonal regeneration through Schwann cell-seeded guidance channels after spinal cord injury.
Deng LX; Hu J; Liu N; Wang X; Smith GM; Wen X; Xu XM
Exp Neurol; 2011 Jun; 229(2):238-50. PubMed ID: 21316362
[TBL] [Abstract][Full Text] [Related]
10. Alterations in chondroitin sulfate proteoglycan expression occur both at and far from the site of spinal contusion injury.
Andrews EM; Richards RJ; Yin FQ; Viapiano MS; Jakeman LB
Exp Neurol; 2012 May; 235(1):174-87. PubMed ID: 21952042
[TBL] [Abstract][Full Text] [Related]
11. A toll-like receptor 9 antagonist improves bladder function and white matter sparing in spinal cord injury.
David BT; Sampath S; Dong W; Heiman A; Rella CE; Elkabes S; Heary RF
J Neurotrauma; 2014 Nov; 31(21):1800-6. PubMed ID: 24936867
[TBL] [Abstract][Full Text] [Related]
12. Attenuated Reactive Gliosis and Enhanced Functional Recovery Following Spinal Cord Injury in Null Mutant Mice of Platelet-Activating Factor Receptor.
Wang Y; Gao Z; Zhang Y; Feng SQ; Liu Y; Shields LBE; Zhao YZ; Zhu Q; Gozal D; Shields CB; Cai J
Mol Neurobiol; 2016 Jul; 53(5):3448-3461. PubMed ID: 26084439
[TBL] [Abstract][Full Text] [Related]
13. TGF-alpha increases astrocyte invasion and promotes axonal growth into the lesion following spinal cord injury in mice.
White RE; Yin FQ; Jakeman LB
Exp Neurol; 2008 Nov; 214(1):10-24. PubMed ID: 18647603
[TBL] [Abstract][Full Text] [Related]
14. Nucleolin inhibitor GroA triggers reduction in epidermal growth factor receptor activation: Pharmacological implication for glial scarring after spinal cord injury.
Goldshmit Y; Schokoroy Trangle S; Afergan F; Iram T; Pinkas-Kramarski R
J Neurochem; 2016 Sep; 138(6):845-58. PubMed ID: 27399849
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor α transforms astrocytes to a growth-supportive phenotype after spinal cord injury.
White RE; Rao M; Gensel JC; McTigue DM; Kaspar BK; Jakeman LB
J Neurosci; 2011 Oct; 31(42):15173-87. PubMed ID: 22016551
[TBL] [Abstract][Full Text] [Related]
16. A novel compound, denosomin, ameliorates spinal cord injury via axonal growth associated with astrocyte-secreted vimentin.
Teshigawara K; Kuboyama T; Shigyo M; Nagata A; Sugimoto K; Matsuya Y; Tohda C
Br J Pharmacol; 2013 Feb; 168(4):903-19. PubMed ID: 22978525
[TBL] [Abstract][Full Text] [Related]
17. NG2 and phosphacan are present in the astroglial scar after human traumatic spinal cord injury.
Buss A; Pech K; Kakulas BA; Martin D; Schoenen J; Noth J; Brook GA
BMC Neurol; 2009 Jul; 9():32. PubMed ID: 19604403
[TBL] [Abstract][Full Text] [Related]
18. Conditional Sox9 ablation improves locomotor recovery after spinal cord injury by increasing reactive sprouting.
McKillop WM; York EM; Rubinger L; Liu T; Ossowski NM; Xu K; Hryciw T; Brown A
Exp Neurol; 2016 Sep; 283(Pt A):1-15. PubMed ID: 27235933
[TBL] [Abstract][Full Text] [Related]
19. Single, high-dose intraspinal injection of chondroitinase reduces glycosaminoglycans in injured spinal cord and promotes corticospinal axonal regrowth after hemisection but not contusion.
Iseda T; Okuda T; Kane-Goldsmith N; Mathew M; Ahmed S; Chang YW; Young W; Grumet M
J Neurotrauma; 2008 Apr; 25(4):334-49. PubMed ID: 18373483
[TBL] [Abstract][Full Text] [Related]
20. Epac2 Elevation Reverses Inhibition by Chondroitin Sulfate Proteoglycans
Guijarro-Belmar A; Viskontas M; Wei Y; Bo X; Shewan D; Huang W
J Neurosci; 2019 Oct; 39(42):8330-8346. PubMed ID: 31409666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
